CASE SERIES OF NEOVASCULAR GLAUCOMA:EARLY LIMITEDTRANS-SCLERAL CYTOPHOTOCOAGULATIONS (TSCPC) AS AN OPTIONS FOR PREPARATION OF FILTERING SURGERY IN NVG PATIENTS CAN SAVE PATIENT’S VISIONS
Neovascular Glaucoma (NVG) is a severe form of secondary glaucoma characterized by proliferation of fibrovascular tissue in the anterior chamber angle. Clinically rubeosis iridis was seen at the pupillary margin and angle via gonioscopy.NVG results in guarded visual prognosis in view of aggressive clinical course and the difficulty in controlling the intraocular pressure(IOP).Patient treatment is indivdualized by taking into account patient visual prognosis, severity, level ofIOP, the cause of NVG, financial issues and patient’s expectations. Trans-scleral cytophotocoagulations is one of the modalities available to reduce the intraocular pressure, usually reserved for the poor prognosis eye in view of its destructive nature . TSCPC in a good prognosis eye is always used in cautions.In this case series, we present 3 case of NVG whichwe use the early limited TSCPC to reduce the IOP to buy time for other managementsin which patient have good visual outcome.
Keywords:TSCPC in NVG, Neovascular Glaucoma, TSCPC , CPC, Filtering Surgery
Fong, A.W., Lee, G.A., O'Rourke, P. & Thomas, R. (2011) Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Clinical & Experimental Ophthalmology, 39(4); pp:318-323.
Moharram, H.M., Abd-ElhamidMehanyElwan, S., Nassar, M.M. & Abdelkader, M.F. (2020) Triple Procedure for Dense Cataractous Neovascular Glaucoma Patients. Journal of Ophthalmology, 2020.
Moraczewski, A.L., Lee, R.K., Palmberg, P.F., Rosenfeld, P.J. & Feuer, W.J. (2009) Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. British Journal of Ophthalmology, 93(5); pp:589-593.
Noor, N.A., Mustafa, S. & Artini, W. (2017) Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience. Clinical Ophthalmology (Auckland, NZ), 11, pp:1417.
Park, U.C., Park, K.H., Kim, D.M. & Yu, H.G. (2011) Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. Journal of Glaucoma, 20(7); pp:433-438.
Takihara, Y., Inatani, M., Fukushima, M., Iwao, K., Iwao, M. & Tanihara, H. (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. American Journal of Ophthalmology, 147(5); pp:912-918.
Yildirim, N., Yalvac, I.S., Sahin, A., Ozer, A. & Bozca, T. (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up. Journal of Glaucoma, 18(3); pp:192-196.
How to Cite
Copyright (c) 2021 Malaysian Journal of Medical Research (MJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.